SCHEMBL2471069

SCHEMBL2471069

O=C(c1cc(N=Nc2ccccc2)ccc1O)C(O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.54
KMT2A Q03164 6/20 0.54
BLVRB P30043 2/20 0.54
PDE4A P27815 1/20 0.54
KDR P35968 1/20 0.54
HTT P42858 1/20 0.54
TDP1 Q9NUW8 4/20 0.53
APP P05067 1/20 0.53
THRB P10828 1/20 0.53
RECQL P46063 1/20 0.53
BLM P54132 1/20 0.53
TSHR P16473 2/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
GLO1 Q04760 2/20 0.47
ALDH1A1 P00352 3/20 0.47
PHLPP2 Q6ZVD8 2/20 0.47
CYP2C9 P11712 2/20 0.47
PTGS1 P23219 1/20 0.47
PTGS2 P35354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29564256 0.80 CA12 (0.53) MEN1KMT2ATSHRALDH1A1PTGS2
SCHEMBL137145 0.79 MEN1 (0.85) MEN1KMT2ABLVRBPDE4AKDR
SCHEMBL137146 0.79 MEN1 (0.85) MEN1KMT2ABLVRBPDE4AKDR
SCHEMBL15339774 0.79 MEN1 (0.85) MEN1KMT2ABLVRBPDE4AKDR
SCHEMBL28847216 0.78 MEN1 (0.82) MEN1KMT2ABLVRBPDE4AKDR
SCHEMBL20483076 0.77 IDE (0.51) MEN1KMT2ATDP1CYP2D6CYP2C19
SCHEMBL252921 0.76 LMNA (0.59) MEN1KMT2AHTTTSHRCYP2C19
SCHEMBL16937237 0.75 IDE (0.66) MEN1KMT2ATDP1THRBALDH1A1
SCHEMBL29950230 0.75 MEN1 (0.61) MEN1KMT2ABLVRBPDE4AKDR
SCHEMBL27985065 0.75 MEN1 (0.61) MEN1KMT2ABLVRBPDE4AKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2549999-A1 AZO COMPOUNDS REDUCING FORMATION AND TOXICITY OF AMYLOID BETA AGGREGATION INTERMEDIATES Max-Delbrück-Centrum für Molekulare Medizin (DE) 2013-01-30 EP disclosed
WO-2011117305-A1 AZO COMPOUNDS REDUCING FORMATION AND TOXICITY OF AMYLOID BETA AGGREGATION INTERMEDIATES Max-Delbrück-Centrum für Molekulare Medizin (DE) 2011-09-29 WO disclosed
EP-2368558-A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates Mdc Max-Delbrück-Centrum Für Molekulare Medizin Berlin - Buch (DE) 2011-09-28 EP disclosed